Related Experiment Video
Updated: Mar 9, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.5K
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy
Mariana Babayeva1, Haregewein Assefa1, Paramita Basu1
1Touro College of Pharmacy, 230 West 125th Street, Room 530, New York, NY 10027, USA.
Parkinson'S Disease
|January 5, 2017
Summary
Medical marijuana may offer new hope for Parkinson's disease (PD) patients. Research explores cannabis compounds for treating motor and non-motor symptoms, potentially improving quality of life.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by the loss of dopamine neurons.
- Current treatments for PD primarily replace dopamine, offering symptomatic relief for motor deficits but causing adverse effects like dyskinesia.
Approach:
- This review examines the therapeutic potential of cannabis and its related compounds for managing Parkinson's disease.
- The focus is on evaluating cannabis for both motor and non-motor symptoms and its disease-modifying capabilities.
Key Points:
- Cannabis compounds show promise in addressing the complex symptoms of Parkinson's disease.
- Medical marijuana may offer a more comprehensive approach to PD management beyond dopamine replacement.
- Research is exploring the neuroprotective and symptomatic benefits of cannabinoids in PD.
Conclusions:
- Cannabis-based therapies present a potential avenue for improving the quality of life for individuals with Parkinson's disease.
- Further research is warranted to fully understand the efficacy and safety of medical marijuana in PD treatment.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
872
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
872
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
995
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
995